Evidence map›Paper›PMID 24749061›Full record

ArticleMolecular metabolism2014

Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus.

Juxue Li, Yizhe Tang, Sudarshana Purkayastha, Jingqi Yan, Dongsheng Cai

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dietary Regulation of Adult Stem Cells.Current stem cell reports · 2017
    Article
  17. POMC Neurons: From Birth to Death.Annual review of physiology · 2017
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Juxue LiDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, USA ; Diabetes Research Center, Albert Einstein College of Medicine, USA ; Institute of Aging, Albert Einstein College of Medicine, USA.
Yizhe TangDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, USA ; Diabetes Research Center, Albert Einstein College of Medicine, USA ; Institute of Aging, Albert Einstein College of Medicine, USA.
Sudarshana PurkayasthaDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, USA ; Diabetes Research Center, Albert Einstein College of Medicine, USA ; Institute of Aging, Albert Einstein College of Medicine, USA.
Jingqi YanDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, USA ; Diabetes Research Center, Albert Einstein College of Medicine, USA ; Institute of Aging, Albert Einstein College of Medicine, USA.
Dongsheng CaiDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, USA ; Diabetes Research Center, Albert Einstein College of Medicine, USA ; Institute of Aging, Albert Einstein College of Medicine, USA.
Albert Einstein College of Medicine · US

Funding

The Hypothalamic Basis of AgingR01AG031774 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Dongsheng Cai · 2010 to 2026
$6.3M
Role of IKK-Beta/NF-KappaB in Hypothalamic Dysregulation of Energy BalanceR01DK078750 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI CAI, DONGSHENG · 2008 to 2017
$3.8M
Hypothalamic IKK-beta in obesity-related hypertensionR01HL113180 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CAI, DONGSHENG · 2013 to 2016
$1.9M
NHLBI NIH HHS R01 HL113180NIA NIH HHS R01 AG031774NIDDK NIH HHS R01 DK078750
6 · The paper itself

Abstract

Neural stem cells (NSCs) were recently revealed to exist in the hypothalamus of adult mice. Here, following our observation showing that a partial loss of hypothalamic NSCs caused weight gain and glucose intolerance, we studied if NSCs-based cell therapy could be developed to control these disorders. While hypothalamus-implanted NSCs failed to survive in mice with obesity, NF-κB inhibition induced survival and neurogenesis of these cells, leading to effects in counteracting obesity and glucose intolerance. To generate an alternative cell source, we revealed that iPS-derived NSCs were converted into htNSCs by neuropeptide treatment. Of note, obesity condition potentiated the transfer of carotid artery-injected NSCs into the hypothalamus. These iPS-derived cells when engineered with NF-κB inhibition were also effective in reducing obesity and glucose intolerance, and neurogenesis towards POMCergic and GABAergic lineages was accountable. In conclusion, building NSCs in the hypothalamus represents a strategy for controlling obesity and glucose disorders.

Indexed as

Glucose toleranceHypothalamusiPSNeural stem cellsNeuropeptideNF-κBObesity

Identifiers

PMID24749061
PMCPMC3986657
OpenAlexW2131320317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.